PFM Health Sciences LP 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:07 pm Sale | 2024-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 2,905,465 6.500% | -493,282 (-14.51%) | Filing |
| 2024-11-14 4:04 pm Sale | 2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 3,398,747 7.800% | -69,430 (-2.00%) | Filing |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 3,468,177 9.600% | 1,646,357 (+90.37%) | Filing |
| 2023-01-17 4:01 pm Purchase | 2023-01-06 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,821,820 5.300% | 528,527 (+40.87%) | Filing |
| 2023-01-17 1:20 pm Sale | 2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,293,293 4.200% | -223,733 (-14.75%) | Filing |
| 2022-05-02 4:02 pm Purchase | 2022-04-21 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,517,026 5.500% | 1,517,026 (New Position) | Filing |